Black patients fare well on Vertex hepatitis C drug
by on Oct.30, 2010, under Health and Fitness
A closer look at data from a late stage trial of Vertex Pharmaceuticals Inc's eagerly anticipated hepatitis C drug telaprevir showed impressive cure rates for black patients and for patients with advanced liver disease.
View full post on Yahoo! Health News
